An open labelled, two armed prospective, randomized controlled Phase II, pilot clinical study to evaluate efficacy of immunity booster in covid survivors.

Abstract

This clinical study investigated the effect of Immunity booster in Post-COVID-19 survivors who had experienced prolonged symptoms such as fatigue, recurrent infections, reduced energy, cognitive disturbances, and immune dysregulation—collectively referred to as Post-COVID Syndrome or Long COVID. Persistent inflammation and impaired immune homeostasis are key contributing factors. Traditional Ayurvedic formulations, known for their Rasayana (rejuvenative) and Ojas-vardhaka (immunity-enhancing) properties, may provide a holistic approach to immune restoration. This study was designed to evaluate the efficacy and safety of an herbal-based Immunity Booster formulation in improving immune function and quality of life among post-COVID survivors.